Peptides that regulate food intake: glucagon-like peptide 1-(7-36) amide acts at lateral and medial hypothalamic sites to suppress feeding in rats - PubMed

Affiliations

• PMID: 12776726
• DOI: 10.1152/ajpregu.00479.2002

Free article

Peptides that regulate food intake: glucagon-like peptide 1-(7-36) amide acts at lateral and medial hypothalamic sites to suppress feeding in rats

Rafael R Schick et al. Am J Physiol Regul Integr Comp Physiol. 2003 Jun.

Free article

Abstract

Glucagon-like peptide 1-(7-36) amide (GLP-1) potently inhibits rat feeding behavior after central administration. Because third ventricular injection of GLP-1 appeared to be less effective than lateral ventricular injection, we have reexamined this issue. In addition, we attempted to identify brain regions other than the paraventricular nucleus of the hypothalamus that are sensitive toward GLP-1-induced feeding suppression. Finally, we examined the local role of endogenous GLP-1 by specific GLP-1 receptor blockade. After lateral ventricular injection, GLP-1 significantly inhibited food intake of 24-h-fasted rats in a dose-dependent fashion with a minimal effective dose of 1 microg. After third ventricular injection, GLP-1 (1 microg) was similarly effective in suppressing food intake, which extends previous findings. Intracerebral microinjections of GLP-1 significantly suppressed food intake in the lateral (LH), dorsomedial (DMH), and ventromedial hypothalamus (VMH), but not in the medial nucleus of the amygdala. The minimal effective dose of GLP-1 was 0.3 microg at LH sites and 1 microg at DMH or VMH sites. LH microinjections of exendin-(9-39) amide, a GLP-1 receptor antagonist, at 1 or 2.5 microg did not alter feeding behavior in 24-h-fasted rats. In satiated animals, however, a single LH injection of 1 microg exendin-(9-39) amide significantly augmented food intake, but only during the first 20 min (0.6 vs. 0.1 g). With three repeated injections of 2.5 microg exendin-(9-39) amide every 20 min, 1-h food intake was significantly increased by 300%. These data strongly support and extend the concept of GLP-1 as a physiological regulator of food intake in the hypothalamus.

Similar articles

• Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake.

  Navarro M, Rodriquez de Fonseca F, Alvarez E, Chowen JA, Zueco JA, Gomez R, Eng J, Blázquez E. Navarro M, et al. J Neurochem. 1996 Nov;67(5):1982-91. doi: 10.1046/j.1471-4159.1996.67051982.x. J Neurochem. 1996. PMID: 8863504

• Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.

  Larsen PJ, Tang-Christensen M, Jessop DS. Larsen PJ, et al. Endocrinology. 1997 Oct;138(10):4445-55. doi: 10.1210/endo.138.10.5270. Endocrinology. 1997. PMID: 9322962

• A role for glucagon-like peptide-1 in the central regulation of feeding.

  Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J, Bloom SR. Turton MD, et al. Nature. 1996 Jan 4;379(6560):69-72. doi: 10.1038/379069a0. Nature. 1996. PMID: 8538742

• GLP-1 and weight loss: unraveling the diverse neural circuitry.

  Kanoski SE, Hayes MR, Skibicka KP. Kanoski SE, et al. Am J Physiol Regul Integr Comp Physiol. 2016 May 15;310(10):R885-95. doi: 10.1152/ajpregu.00520.2015. Epub 2016 Mar 30. Am J Physiol Regul Integr Comp Physiol. 2016. PMID: 27030669 Free PMC article. Review.

• Glucagon-Like Peptide-1 (GLP-1) in the Integration of Neural and Endocrine Responses to Stress.

  Diz-Chaves Y, Herrera-Pérez S, González-Matías LC, Lamas JA, Mallo F. Diz-Chaves Y, et al. Nutrients. 2020 Oct 28;12(11):3304. doi: 10.3390/nu12113304. Nutrients. 2020. PMID: 33126672 Free PMC article. Review.

Cited by

• Pro-protein convertases in intermediary metabolism: islet hormones, brain/gut hormones and integrated physiology.

  Bataille D. Bataille D. J Mol Med (Berl). 2007 Jul;85(7):673-84. doi: 10.1007/s00109-007-0167-4. Epub 2007 Mar 14. J Mol Med (Berl). 2007. PMID: 17356847 Review.

• Gene therapy for diabetes: metabolic effects of helper-dependent adenoviral exendin 4 expression in a diet-induced obesity mouse model.

  Samson SL, Gonzalez EV, Yechoor V, Bajaj M, Oka K, Chan L. Samson SL, et al. Mol Ther. 2008 Nov;16(11):1805-12. doi: 10.1038/mt.2008.198. Epub 2008 Sep 9. Mol Ther. 2008. PMID: 18781141 Free PMC article.

• GLP-1 Suppresses Feeding Behaviors and Modulates Neuronal Electrophysiological Properties in Multiple Brain Regions.

  Chen XY, Chen L, Yang W, Xie AM. Chen XY, et al. Front Mol Neurosci. 2021 Dec 17;14:793004. doi: 10.3389/fnmol.2021.793004. eCollection 2021. Front Mol Neurosci. 2021. PMID: 34975402 Free PMC article. Review.

• Differential Effects of Linagliptin on the Function of Human Islets Isolated from Non-diabetic and Diabetic Donors.

  Zhang Y, Wu M, Htun W, Dong EW, Mauvais-Jarvis F, Fonseca VA, Wu H. Zhang Y, et al. Sci Rep. 2017 Aug 11;7(1):7964. doi: 10.1038/s41598-017-08271-9. Sci Rep. 2017. PMID: 28801559 Free PMC article.

• The role of glucagon-like peptide-1 (GLP-1) in fluid and food intakes in vasopressin-deficient Brattleboro rats.

  Brakey DJ, Schatz KC, Paul MJ, Daniels D. Brakey DJ, et al. Physiol Behav. 2023 Apr 1;262:114093. doi: 10.1016/j.physbeh.2023.114093. Epub 2023 Jan 24. Physiol Behav. 2023. PMID: 36706972 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon

• Other Literature Sources

  • The Lens - Patent Citations Database